DIAMOND STUART
Insider CIK 1259438 · BIAF Director · MRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BIAF bioAffinity Technologies, | A Award | 2024-07-01 | 2024-07-02 | 33,784 | — | $0 | 99,088 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2024-06-12 | 2024-06-14 | 8,296 | — | $0 | 65,304 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2024-01-01 | 2024-01-24 | 12,668 | $1.48 | $18.7K | 57,008 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2023-10-01 | 2024-01-24 | 11,867 | $1.58 | $18.7K | 44,340 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2023-07-01 | 2023-07-06 | 10,245 | $1.83 | $18.7K | 32,473 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2023-04-15 | 2023-07-06 | 9,920 | $1.89 | $18.7K | 22,228 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2023-01-01 | 2023-07-06 | 8,227 | $2.28 | $18.8K | 12,308 | SEC↗ |
| BIAF bioAffinity Technologies, | P Buy deriv | 2022-08-31 | 2022-12-02 | 4,081 | — | $0 | 4,081 | SEC↗ |
| BIAF bioAffinity Technologies, | P Buy deriv | 2022-08-31 | 2022-12-02 | 4,081 | — | $0 | 4,081 | SEC↗ |
| BIAF bioAffinity Technologies, | P Buy | 2022-08-31 | 2022-12-02 | 4,081 | — | $0 | 4,081 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 7,500 | $11.65 | $87.4K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 21,000 | $14.70 | $308.7K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $11.44 | $171.6K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $28.11 | $421.6K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $20.38 | $305.7K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 6,842 | $7.71 | $52.8K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $10.19 | $152.8K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $21.21 | $318.1K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 7,743 | $6.15 | $47.6K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 21,000 | $4.96 | $104.2K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer | 2012-12-11 | 2012-12-13 | 8,675 | $44.00 | $381.7K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | M Exercise deriv | 2012-08-20 | 2012-08-22 | 17,500 | — | $0 | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | M Exercise | 2012-08-20 | 2012-08-22 | 17,500 | $22.40 | $392.0K | 26,175 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | S Sale | 2012-08-20 | 2012-08-22 | 17,500 | $32.76 | $573.3K | 8,675 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | A Award deriv | 2012-05-15 | 2012-05-17 | 7,743 | — | $0 | 7,743 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | A Award | 2012-05-15 | 2012-05-17 | 2,311 | — | $0 | 8,675 | SEC↗ |